The First Cohort homepage — Bold Populist Front layout with oversized lead story, secondary story tier, and compact story list

The First Cohort
Medical research, with the receipts
Cancer Research — Preclinical

A Korean lab found cancer's DNA-repair off-switch. In a mouse.

A tool compound strips the DNA-repair proteins tumors use to dodge PARP inhibitors. Preclinical only — but the gap between treated and control animals is the story.

Tumor clearance at 8 weeks
94% 12% Treated Control
Source: Korean lab preclinical study, 2026 — tumor clearance rates, treated vs. untreated cohorts
Metabolic

Where your sodium actually comes from

Roughly 71% from processed food. The saltshaker? Six to twenty percent. The dietary advice has been pointing at the wrong villain for decades.

~71% processed food 6–20% Source: dietary sodium intake studies
Drugs & FDA

Europe had this sunscreen in 1999. The FDA approved it Tuesday.

Twenty-seven years in regulatory limbo while American consumers used inferior UV filters. The approval finally closes a gap the dermatology community stopped pretending didn't exist.

Investigations

A Senate subcommittee just put the COVID-shot cancer question on the record

Not a fringe newsletter. Not social media. A Senate subcommittee. The hearings are now a matter of public record — whatever the institutional press chooses to do with that.

More stories
Infectious Disease A DoD-funded fentanyl vaccine is headed to Phase 1 Marcus Chen · 7 min
Brain & Aging The Alzheimer's drug that bets the plaques are a symptom Sarah Okonkwo · 5 min
Autoimmune Fish oil rewired the T-cells in non-obese diabetic rats Sarah Okonkwo · 4 min
Cancer ALTAIR missed its endpoint. The press tour found something else. Lena Marshall · 7 min
Nutrition The thin trial behind England's next supermarket-layout mandate Marcus Chen · 6 min
Investigations The $401 CBC and the $32 CBC are the same test Lena Marshall · 5 min
Investigations A 16-foot fire tornado burned an oil slick with 40% less soot Sarah Okonkwo · 6 min